China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA: 600062)

China Resources Double-Crane Pharmaceutical Co.,Ltd. Revenue

China Resources Double-Crane Pharmaceutical Co.,Ltd. had revenue of 2.62B CNY in the quarter ending September 30, 2024, with 0.55% growth. This brings the company's revenue in the last twelve months to 10.32B, down -5.44% year-over-year. In the year 2023, China Resources Double-Crane Pharmaceutical Co.,Ltd. had annual revenue of 10.22B with 6.20% growth.

• Revenue (ttm): 10.32B
• Revenue Growth: -5.44%
• P/S Ratio: 2.20
• Revenue / Employee: 841.30K
• Employees: 12,269
• Market Cap: 22.67B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	10.22B	596.82M	6.20%
Dec 31, 2022	9.63B	513.80M	5.64%
Dec 31, 2021	9.11B	607.58M	7.14%
Dec 31, 2020	8.50B	-877.05M	-9.35%
Dec 31, 2019	9.38B	1.16B	14.05%